XML 49 R37.htm IDEA: XBRL DOCUMENT v3.3.1.900

Organization of the Company (Details Textuals) $ in Thousands	12 Months Ended
	Dec. 31, 2015 USD ($)
Controlled Equity Offering Sales Agreement | Cantor Fitzgerald & Co., ("Cantor")
Organization [Line Items]
Maximum amount of offering price for common stock	$ 8,350
Proceeds received through sale of shares	500
United kingdoms medical research council | Investigational new drug (IND)
Organization [Line Items]
Grant award amount	1,900
Biomedical catalyst of United Kingdom government | Investigational new drug (IND)
Organization [Line Items]
Grant award amount	$ 3,500

X

- Definition

Represents maximum amount of offering price for common stock.

+ References

No definition available.

+ Details

Name:	cycc_MaximumAmountOfOfferingPriceForCommonStock
Namespace Prefix:	cycc_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table.

+ References

No definition available.

+ Details

Name:	cycc_OrganizationLineItems
Namespace Prefix:	cycc_
Data Type:	xbrli:stringItemType
Balance Type:	na
Period Type:	duration

X

- Definition

Cash received from grantors during the current period related to operating activities. This element represents receipts from a guarantor for the amount of guarantee provided.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 25
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3536-108585

+ Details

Name:	us-gaap_ProceedsFromGrantors
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Definition

The cash inflow from the issuance of common stock, preferred stock, treasury stock, stock options, and other types of equity.

+ References

Reference 1: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Glossary Financing Activities
-URI http://asc.fasb.org/extlink&oid=6513228

Reference 2: http://www.xbrl.org/2003/role/presentationRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 14
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=56944662&loc=d3e3255-108585

+ Details

Name:	us-gaap_ProceedsFromIssuanceOrSaleOfEquity
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	debit
Period Type:	duration

X

- Details

Name:	cycc_AgreementAxis=cycc_ControlledEquityOfferingSalesAgreementMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	us-gaap_TitleOfIndividualAxis=cycc_SalesAgentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cycc_GrantAwardeeAxis=cycc_UnitedKingdomsMedicalResearchCouncilMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cycc_ProgramAxis=cycc_InvestigationalNewDrugMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type:

X

- Details

Name:	cycc_GrantAwardeeAxis=cycc_BiomedicalCatalystOfTheUnitedKingdomGovernmentMember
Namespace Prefix:
Data Type:	na
Balance Type:
Period Type: